EVERSANA

Direct-to-Patient (DTP) models are redefining healthcare journeys by making care more accessible, affordable and patient-centered. At this year’s Frontiers Health event, EVERSANA’s Scott Snyder hosted an engaging panel discussion exploring how DTP models give patients greater control over their care while simplifying access to therapies. Curious about the insights shared and the growing impact of DTP models? Dive into the key takeaways from the panel discussion here: https://ow.ly/7moq50Uq8XY

Unreliable and missing eBV “results” drain time, money and resources in #patientsupport programs. ACTICS® eAccess solves this challenge by fully understanding a patient’s specific profile to predict their OOP down to the dollar. By elevating the entire #eBV processes, EVERSANA is helping life sciences brands accelerate therapy initiation and reduce the time and resources required to verify coverage. Schedule a meeting to learn more about the impact of ACTICS® eAccess: https://lnkd.in/gbZwQdUU

Congratulations are in order for Eduard de Vries Sands, CIO, as he has been listed as a Global Finalist for the 2025 Tennessee ORBIE Awards. The Tennessee ORBIE Awards honor chief information officers who have demonstrated excellence in technology leadership. For more information, read here: https://lnkd.in/g2bKQn8V

In our third annual state of #BrandPlanning report, we uncover some unexpected and worrying trends that call for a strategic rethink. Discover how industry leaders Sean Rapson, Managing Director, EVERSANA MANAGEMENT CONSULTING, John Kenny, PhD, Chief Strategy Officer, EVERSANA INTOUCH, and Emily Bradshaw, Senior Consultant, EVERSANA MANAGEMENT CONSULTING, are navigating these changes and what they mean for the future of brand planning. Access the POV: https://ow.ly/r63N50UYKgN

For the third and fourth consecutive year, the EVERSANA CONSULTING team in the Asia Pacific and North America Regions has been named a Top Ranked Consulting firm by the experts at Vault! Vault's rankings are based on exclusive insider information from verified employees in the consulting industry’s feedback on the firm’s prestige, quality of life, and overall best place to work across several categories. Read more: https://lnkd.in/g_4GX8D4

Our Field Sales Team is Growing! Join our innovative field sales team as we expand our focus in several specialties. We're looking for passionate sales representatives dedicated to improving patient outcomes and driving success in the healthcare industry. At EVERSANA, we're committed to creating a healthier world through cutting-edge therapies and exceptional service. Be part of a company that values diversity and patient success. 🔗 Ready to make a difference? Apply now and be a part of our journey! https://lnkd.in/gmuA6Jdc #HealthcareInnovation #SalesJobs #JoinOurTeam #career #hiring

EVERSANA is a proud Platinum Sponsor of the World EPA Congress 2025, the world’s leading healthcare evidence, pricing and access congress. Join us March 5-6 in Amsterdam, where EVERSANA’s thought leaders will deliver presentations on: ◾ Securing Launch Success in Europe and the Role of Data and the JCA ◾ Key Global Drug Pricing Trends Visit EVERSANA’s team in booth #19 throughout the conference and click here to learn more: https://ow.ly/8YMG50UOOfk

Navigating today's fragmented global healthcare infrastructure is complex. EVERSANA COMPLETE Commercialization® offers an end-to-end solution that delivers clinical and commercial benefits, cost savings, and operational efficiency. Our model supports over 40 complex therapies across various therapeutic areas. Learn how we can help you achieve global market success.  https://ow.ly/rHZ050ULnGg #GlobalHealthcare #PharmaCommercialization

Achieving maximum revenue requires more than innovation – it demands strategic foresight and seamless execution. In our blog, Faruk Abdullah and Farah Ahmad explore how an integrated commercialization approach can unlock a product’s full revenue potential. Explore why starting commercial activities early, avoiding fragmented vendor ecosystems and adopting a holistic commercialization approach are critical to long-term success. Read the full blog here: https://ow.ly/pi1Q50UMNNC #Pharma #RevenueOptimization #Commercialization #DrugLaunch #COMPLETECommercialization

EVERSANA and Lyfegen have joined forces to transform the landscape of drug pricing and patient access. By leveraging AI-driven insights, this collaboration aims to empower market access teams with the tools they need to make more informed and equitable decisions. CEO Jim Lang shares his insights on this collaboration. Discover more: https://lnkd.in/gP7UxTJD #HealthcareInnovation #DrugPricing #PatientAccess